Stefanie Lesch

Stefanie Lesch is a Senior Scientist in Cell Therapy at AstraZeneca, leveraging over seven years of experience in cancer immunotherapy. They completed a PhD in Medical Research at Ludwig Maximilian University of Munich, where they developed a novel strategy to enhance CAR T cell activity in pancreatic cancer. Stefanie's postdoctoral research at the University of Pennsylvania focused on in vivo generation of CAR T cells, contributing to the field of cellular immunotherapy. Their expertise includes various advanced techniques in tissue culture, gene editing, and immunological assays, with a commitment to advancing immuno-oncology and gene therapy.